Peptide Guides

TB-500 (Thymosin Beta-4): Complete Recovery Peptide Guide

Peptide Playbook Team·2026-02-17T12:00:00Z·11 min read

Key Takeaways

  • TB-500 is a synthetic fragment of thymosin beta-4, a naturally occurring peptide involved in tissue repair, cell migration, and inflammation reduction.
  • It promotes healing across multiple tissue types — muscle, tendon, ligament, bone, skin, heart, brain, and eyes.
  • TB-500 works by upregulating actin, a cell-building protein essential for cell migration and tissue remodeling.
  • It's commonly stacked with BPC-157 for synergistic healing effects through complementary mechanisms.
  • Research is primarily preclinical, but clinical experience from regenerative medicine practitioners is extensive.
  • Always use TB-500 under the guidance of a qualified provider with proper sourcing from licensed pharmacies.

Introduction

If you're dealing with a stubborn injury, slow recovery, or chronic tissue damage, TB-500 is one of the most talked-about peptides in regenerative medicine. Known formally as a synthetic fragment of thymosin beta-4 (Tβ4), TB-500 has earned a reputation as a powerful recovery and healing peptide among athletes, biohackers, and integrative medicine practitioners.

In this comprehensive guide from Peptide Playbook, we'll cover everything you need to know about TB-500 — what it is, how it works, what the research shows, dosing protocols, side effects, and how to use it safely and effectively.

What Is TB-500?

Thymosin Beta-4: The Parent Molecule

Thymosin beta-4 (Tβ4) is a 43-amino-acid peptide that's present in virtually every cell in the human body. It was originally isolated from the thymus gland (hence "thymosin") but is now known to be produced by most tissues. It's one of the most abundant intracellular peptides in the human body.

Tβ4's primary biological function is binding and sequestering actin — the protein that forms the structural scaffolding of cells and drives cell movement. By regulating actin, Tβ4 plays a central role in:

  • Cell migration to injury sites
  • Blood vessel formation (angiogenesis)
  • Tissue remodeling and repair
  • Inflammation regulation
  • Stem cell activation and differentiation

TB-500: The Active Fragment

TB-500 refers to a synthetic version of the active region of thymosin beta-4. The term "TB-500" is widely used in the peptide community, though in research literature you'll more commonly see "thymosin beta-4" or "Tβ4." The active sequence responsible for most of Tβ4's healing properties is the 17-amino-acid fragment known as Ac-SDKP (the N-terminal fragment) and the central actin-binding domain.

For practical purposes, when people refer to TB-500, they're talking about a peptide that replicates the healing and recovery properties of endogenous thymosin beta-4.

How TB-500 Works

Actin Regulation

TB-500's primary mechanism is the upregulation of actin. Actin is a critical structural protein that:

  • Forms the cytoskeleton (internal scaffolding) of cells
  • Drives cell migration — the movement of cells to injury sites
  • Enables cell proliferation — the multiplication of repair cells
  • Supports cell differentiation — the specialization of stem cells into the tissue types needed for repair

By increasing actin production and organization, TB-500 essentially enhances the body's ability to deploy repair cells to damaged tissue and build new, healthy tissue.

Angiogenesis

TB-500 is a potent promoter of new blood vessel formation. Injured tissue needs oxygen and nutrients to heal, and new blood vessels are the delivery system. Research shows Tβ4 stimulates endothelial cell migration, proliferation, and tube formation — the fundamental processes of angiogenesis.

This is particularly important for injuries with poor blood supply, such as tendon and ligament damage, where slow healing is largely due to inadequate vascularization.

Anti-Inflammatory Effects

TB-500 reduces inflammation through multiple pathways:

  • Downregulation of pro-inflammatory cytokines (IL-1β, TNF-α, IL-6)
  • Upregulation of anti-inflammatory mediators
  • Reduction of inflammatory cell infiltration into damaged tissue
  • Modulation of NF-κB signaling

Importantly, TB-500 reduces excessive inflammation without completely suppressing the inflammatory response — which is necessary for the initial phases of healing.

Stem Cell Recruitment and Activation

Research demonstrates that Tβ4 activates resident stem cells and progenitor cells in damaged tissue. It promotes their migration to injury sites and supports their differentiation into the specific cell types needed for repair — whether that's new muscle fibers, tendon cells, cardiac cells, or neurons.

What Can TB-500 Help With?

Musculoskeletal Injuries

This is the most common application for TB-500:

  • Tendon injuries — Tendinitis, tendinopathy, partial tears. TB-500's angiogenic and cell migration properties are particularly valuable for tendons, which have poor natural blood supply.
  • Ligament injuries — Sprains, partial tears, post-surgical healing.
  • Muscle injuries — Strains, tears, contusions. Tβ4 has been shown to accelerate muscle fiber regeneration and reduce fibrosis (scar tissue).
  • Bone fractures — Research shows Tβ4 promotes osteoblast (bone-building cell) activity and accelerates fracture healing.
  • Joint inflammation — Arthritis, bursitis, and chronic joint pain.

Cardiac Repair

Some of the most compelling Tβ4 research involves cardiac tissue. Studies show that Tβ4:

  • Reduces infarct size (area of damage) after heart attack
  • Activates cardiac progenitor cells
  • Promotes new blood vessel formation in damaged heart tissue
  • Improves cardiac function post-injury
  • Reduces cardiac fibrosis

This research is still primarily in animal models, but it highlights TB-500's remarkable tissue repair capabilities beyond musculoskeletal applications.

Neurological Recovery

Tβ4 has shown neuroprotective and neuroregenerative effects in preclinical research:

  • Promotes neural stem cell proliferation and migration
  • Reduces neuroinflammation after traumatic brain injury
  • Promotes remyelination (repair of nerve insulation) in multiple sclerosis models
  • Improves functional recovery after spinal cord injury

Wound Healing and Skin Repair

TB-500 accelerates wound healing by promoting:

  • Keratinocyte and fibroblast migration to wound sites
  • Collagen deposition (the structural protein of skin)
  • Angiogenesis in the wound bed
  • Reduced scar formation

Eye and Corneal Healing

Thymosin beta-4 has advanced the furthest in clinical development for corneal healing. RGN-259 (a Tβ4-based eye drop) has undergone Phase III clinical trials for neurotrophic keratopathy (corneal damage from nerve dysfunction) and dry eye disease, with positive results.

TB-500 Dosing Protocols

Note: Dosing should always be determined by your healthcare provider based on your specific condition, body weight, and health status. The following represents commonly reported protocols in clinical practice.

Loading Phase (Weeks 1-4)

  • Dose: 5-10 mg per week
  • Frequency: Split into 2-3 injections per week (e.g., 2.5 mg Monday/Thursday or 3.3 mg Monday/Wednesday/Friday)
  • Route: Subcutaneous injection
  • Purpose: Establish therapeutic tissue levels and initiate the healing cascade

Maintenance Phase (Weeks 5-8+)

  • Dose: 2.5-5 mg per week
  • Frequency: 1-2 injections per week
  • Route: Subcutaneous injection
  • Purpose: Sustain the healing response and continue tissue remodeling

Cycling

Many practitioners recommend cycling TB-500 — for example, 8 weeks on followed by 4 weeks off. This allows the body to consolidate healing gains while preventing potential receptor desensitization. Some protocols extend to 12 weeks for more severe injuries.

SponsoredPartner with us — advertise hereContact us

Injection Sites

TB-500 acts systemically — it doesn't need to be injected at the injury site. Common injection locations include the abdomen (periumbilical area), thigh, or deltoid region. Because TB-500 upregulates actin throughout the body, it will migrate to areas of damage regardless of injection location.

TB-500 + BPC-157: The Recovery Stack

The combination of TB-500 and BPC-157 is one of the most popular peptide stacks in regenerative medicine. The rationale is compelling — these peptides work through complementary mechanisms:

  • TB-500 excels at cell migration, angiogenesis, and tissue remodeling (building new tissue).
  • BPC-157 excels at growth factor upregulation, nitric oxide modulation, and cytoprotection (protecting and nurturing tissue).

Together, they address different phases and aspects of the healing process:

  • BPC-157 creates a protective, growth-factor-rich environment
  • TB-500 mobilizes repair cells and builds new blood supply
  • Both reduce inflammation through different pathways
  • The combination may accelerate healing beyond what either peptide achieves alone

Typical Combination Protocol

  • TB-500: 5-10 mg/week (loading) → 2.5-5 mg/week (maintenance)
  • BPC-157: 250-500 mcg twice daily (subcutaneous, near injury site if applicable)
  • Duration: 6-12 weeks depending on injury severity

Learn more about BPC-157 in our detailed peptide guides.

Side Effects and Safety

Common Side Effects

TB-500 is generally well tolerated. Reported side effects include:

  • Injection site reactions — Redness, mild pain, or itching at the injection site. Usually transient.
  • Head rush or lightheadedness — Occasionally reported shortly after injection. Typically brief.
  • Fatigue — Some users report temporary fatigue, particularly during the loading phase.
  • Mild nausea — Uncommon, usually resolves quickly.

Theoretical Concerns

  • Cancer risk: Because Tβ4 promotes angiogenesis and cell proliferation, there's a theoretical concern that it could support tumor growth. The research is mixed — some studies suggest Tβ4 may actually have anti-tumor properties, while others show it's overexpressed in certain cancers. As a precaution, TB-500 is generally avoided in patients with active cancer or a recent cancer history.
  • Excessive tissue growth: At very high doses over extended periods, there's a theoretical concern about excessive tissue remodeling. This is why cycling and medical supervision are important.

Contraindications

  • Active cancer or recent cancer history
  • Pregnancy or breastfeeding
  • Active systemic infection (TB-500 could theoretically enhance pathogen-associated angiogenesis)
  • Known hypersensitivity to thymosin beta-4

For a broader overview of peptide safety considerations, read our guide on peptide safety.

Sourcing and Quality

As with all peptides, sourcing matters critically for TB-500:

  • Use licensed US compounding pharmacies (503A or 503B) — these are regulated and follow manufacturing standards.
  • Request certificates of analysis (COAs) — Verify purity (should be ≥98%), identity, and absence of endotoxins.
  • Avoid "research chemical" suppliers — Products sold "for research purposes only" are unregulated and may contain contaminants or incorrect dosing.
  • Work with a reputable clinic — A good provider will source from verified suppliers and handle reconstitution instructions. Find one through our clinic directory.

Storage and Handling

  • Lyophilized (powder) form: Store at room temperature or refrigerated. Stable for months to years.
  • Reconstituted form: Refrigerate immediately. Use within 3-4 weeks. Do not freeze reconstituted peptide.
  • Reconstitution: Use bacteriostatic water (not sterile water). Gently swirl — do not shake. Allow powder to dissolve completely before drawing.
  • Injection supplies: Use insulin syringes (29-31 gauge). New syringe for each injection. Alcohol swab the vial top and injection site.

Frequently Asked Questions

How quickly does TB-500 work?

Most users report noticeable improvements within 2-3 weeks, with significant healing progress by 4-6 weeks. Severe or chronic injuries may take longer. The loading phase is designed to establish therapeutic tissue levels as quickly as possible.

Can I use TB-500 for prevention?

Some athletes and active individuals use TB-500 prophylactically during intense training periods to support tissue resilience and recovery. While there's limited research on preventive use specifically, the mechanisms (enhanced repair capacity, reduced inflammation) are relevant to injury prevention.

Is TB-500 banned in sports?

Yes. Thymosin beta-4 (and by extension TB-500) is on the World Anti-Doping Agency (WADA) prohibited list under S2 (Peptide Hormones, Growth Factors, and Related Substances). It's banned both in-competition and out-of-competition. Athletes subject to drug testing should not use TB-500.

Do I need to inject at the injury site?

No. TB-500 works systemically. Injecting into the abdominal subcutaneous tissue is the most common approach, and the peptide will migrate to damaged tissue throughout the body. Some practitioners do inject near the injury site for theoretical local concentration benefits, but this isn't required.

The Bottom Line

TB-500 is one of the most versatile and promising recovery peptides available. Its ability to promote healing across virtually every tissue type — through actin upregulation, angiogenesis, anti-inflammatory effects, and stem cell activation — makes it a cornerstone of many regenerative medicine protocols.

While most of the research remains preclinical, the depth of evidence and the extensive clinical experience from practitioners worldwide support TB-500's place as a first-line recovery peptide. Combined with BPC-157, it forms a powerful healing stack that addresses multiple phases of the repair process.

As always, work with a qualified provider, use properly sourced peptides, and monitor your progress with regular check-ins. For more on TB-500 and other recovery peptides, explore our complete peptide database.

Medical Disclaimer

This article is for informational and educational purposes only. It is not medical advice and does not replace consultation with a qualified healthcare provider. TB-500 is not FDA-approved for any medical condition. It is banned by WADA and most sports organizations. Always consult a licensed physician before starting any peptide therapy protocol. Individual results vary, and the long-term safety of TB-500 in humans has not been established through large-scale clinical trials.

Tags

TB-500thymosin beta-4recoveryhealingBPC-157tissue repairangiogenesisinjury recovery
SponsoredPartner with us — advertise hereContact us